Richard W. Keatinge

Health Technology

Consumer Services

Electronic Technology

Profile

Richard W.
Keatinge worked as a Communications Director at Bausch Health Americas, Inc. He was also a Managing Director & VP-Business Development at Valerio Therapeutics SA, Vice President-Business Development at Digital Gene Technologies, Inc., Chief Business Officer at Cytheris SA, and Vice President-Development at FeRx, Inc. Keatinge holds a doctorate from Harvard University and an undergraduate degree from the University of California, Berkeley.

Former positions of Richard W. Keatinge

Companies	Position	End
Bausch Health Americas, Inc. Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ.	Public Communications Contact	-
Digital Gene Technologies, Inc. Digital Gene Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Digital Gene Technologies, Inc. develops technology designed to enable researchers to measure gene expression levels in various disease models. The company is headquartered in La Jolla, CA.	Corporate Officer/Principal	-
Cytheris SA Cytheris SA Pharmaceuticals: MajorHealth Technology Cytheris SA develops and manufactures drugs for immune modulation. It is a clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases. The firm's product CYT107 (glycosylated r-hIL-7), is in clinical development for two targeted indications with urgent medical needs and no current treatments: Progressive Multifocal Leukoencephalopathy (PML) in severely lymphopenic patients and Reduction of complications in Immune Non-Responders with HIV controlled by anti-retroviral treatment (HIV-INR). Cytheris has locations in France and The United States. The company was founded in January 1999 by Michel Morre and is headquartered in Issy-les-Moulineaux, France.	Corporate Officer/Principal	-
FeRx, Inc. FeRx, Inc. Medical SpecialtiesHealth Technology FeRx Inc. develops, manufactures, and distributes magnetic targeted carrier technology for the treatment of cancer. Its technology is used in therapeutic areas and provides technology platform for delivery of small molecules, radionuclides, biologics and genetic vectors. The company was registered in 1997 and is headquartered in San Diego, CA.	Corporate Officer/Principal	-
VALERIO THERAPEUTICS	Corporate Officer/Principal	-

See the detail of Richard W. Keatinge's experience

Training of Richard W. Keatinge

University of California, Berkeley	Undergraduate Degree
Harvard University	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies